Priority Date: 06.06.16 (US 201662346344P)
TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE
- Application ID: EP17810774
- Status: █ Request for examination was made
Applicant
Technology Company
Attorney
operating since 1893
Headquarter in Cleveland
and
38 offices
active in Legal Services
Timeline
- 06.06.2016 - Priority Date (US 201662346344P)
- 14.12.2017 - Publication A1 (WO2017214014)
- 10.04.2019 - Publication A1 (EP3463358)